Amaury Fernández-Montalván

9PUBLICATIONS
16CO-AUTHORS
Biologically active moleculesSurface water quality processes and contaminated sediment assessmentMolecular targetsPharmaceutical delivery technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 22, 2020
Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women.

Olaf Panknin, Andrea Wagenfeld, Wilhelm Bone

|May 03, 2020
Concentration Dependence of the Unbound Partition Coefficient Kpuu and Its Application to Correct for Exposure-Related Discrepancies between Biochemical and Cellular Potency of KAT6A Inhibitors.

Cornelius Trünkle, Christian Lechner, Daniel Korr

|Apr 28, 2020
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase.

Volker K Schulze, Ulrich Klar, Dirk Kosemund

|Aug 25, 2019
Considerations for improved performance of competition association assays analysed with the Motulsky-Mahan's "kinetics of competitive binding" model.

Victoria Georgi, Alexey Dubrovskiy, Stephan Steigele

|May 29, 2019
Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.

Reggie Bosma, Leigh A Stoddart, Victoria Georgi

|Nov 16, 2018
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo.

Gerhard Siemeister, Anne Mengel, Amaury E Fernández-Montalván

Pageof 2

Frequent Collaborators

1 joint publications

Markus Berger

1 joint publications

Vincent Rodeschini

1 joint publications

Apirat Chaikuad

1 joint publications

Mátyás Gorjánácz